BYD
25.3.2026 12:49:40 CET | Globenewswire | Press release
Daniel Craig launches new range for DENZA ahead of global expansion
Daniel Craig launches new range for DENZA ahead of global expansion
PARIS, March 25, 2026 (GLOBE NEWSWIRE) -- BYD is proud to announce that British actor Daniel Craig is launching a new campaign for DENZA, its premium technology-oriented automotive brand, to coincide with its global expansion in 2026.
The world's first premium brand devoted solely to new-energy vehicles for sustainable mobility, DENZA is ready to find new customers drawn by a unique blend of cutting-edge innovations and European-influenced design elegance. As the perfect partner for this process, Daniel Craig will lend his image to several key vehicles being launched this year, including in marketing materials and television commercials.
The partnership with one of the world's most recognisable actors represents significant worldwide recognition for DENZA, which is building up to its first European model launch, for its flagship Z9GT shooting brake, to be held on 8 April at the Palais Garnier opera house in Paris.
BYD Executive Vice President Stella Li commented: “Daniel Craig represents a powerful combination of strength, sophistication and authenticity. Those qualities resonate deeply with what DENZA stands for. As we bring the brand to the world — across Europe, Latin America, the Middle East and Africa — we are proud to welcome an actor whose presence and character reflect the spirit of DENZA. Together, we want to show how technology, design and emotion can come together to create a new vision of premium mobility.”
For more information:
Press Office LaPresse - ufficio.stampa@lapresse.it
A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/366e35ea-f5d4-4571-93ce-655214325b61


Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom